Join us for a Free Webinar on April 10

Space is limited.
Reserve your Webinar seat now at:
https://www1.gotomeeting.com/register/529548529

This live webinar has already taken place, however the archived presentation is still available for you to review
» View Presentation

Clinical validation, high development costs and comparatively low market reimbursement rates present challenges for realizing personalized medicine and bringing value-based companion diagnostic and medical diagnostic tests to market. Gaining the acknowledgment of the "value" in these tests from both drug developers and payors is essential, and a number of strategies have emerged to bring these vital tests to market.

• Learn about value-based diagnostics and why they are prominent in personalized medicine
• Hear how VeriStrat® helps oncologists make treatment decisions in the 2nd line advanced NSCLC setting
• Learn how value-based companion diagnostics enable personalized medicine
• Get a look at new business models that can bring value-based CDx to personalized medicine

Biodesix was founded in 2005 to apply the principles of complex data analysis and mass spectrometry (MS) to the discovery and development of improved multivariate tests that give physicians better information to understand the patient and their disease.

Presenter:
Paul Bereford, PhD, Vice President, Business Development and Strategic Marketing, Biodesix

Paul Beresford is currently the Vice President, Business Development and Strategic Marketing at Biodesix. Prior to Biodesix he was Vice President and General Manager of Translational Diagnostics at Ventana Medical Systems/Roche for eight years.

After registering you will receive a confirmation email containing information about joining the Webinar.

System Requirements
PC-based attendees
Required: Windows® 7, Vista, XP or 2003 Server

Macintosh®-based attendees
Mac OS® X 10.5 or newer